Mirio®

Category:

Description

Solution for monitoring and evaluating patients diagnosed with cancer

Advantages

for each stakeholder

Technical

specifications

MIRIO® provides evaluation of tumour response to cancer treatments:

In clinical trials

  • MIRIO® gives an indication of efficacy in phase I trials
  • It enables comparison of efficacy in phase II (new medicines or strategies)
  • It determines the secondary criteria in phase III

In routine clinical practice

  • MIRIO® provides guidance for the clinician in making decisions concerning treatment
  • It allows for  evaluation of tumour response – an element to be taken into account when deciding on the follow-up to treatment, with clinical benefits and improvement of biological parameters.

MIRIO® is also standardization and security of prescriptions and imaging reports.
Finally, MIRIO® allows for the establishment of a Patient database combining and using clinical, biological, and genomic data.

Need more

information

Discover our other

solutions